BRIEF published on 03/16/2026 at 07:35, 1 month 25 days ago OSE Immunotherapeutics unveils its financial calendar for 2026 Treasury Financial Calendar General Assembly OSE Immunotherapeutics 2026 Financial Results
BRIEF published on 03/16/2026 at 07:29, 1 month 25 days ago UBS AG Announces Agenda for 2026 Annual General Meeting Dividend Proposal Board Elections Share Capital Reduction UBS AGM 2026 Agenda Details
BRIEF published on 03/16/2026 at 07:29, 1 month 25 days ago UBS AG annonce l'ordre du jour de son assemblée générale annuelle de 2026 Proposition De Dividende Élections Du Conseil D'administration Réduction Du Capital Social Assemblée Générale Annuelle D'UBS 2026 Détails De L'ordre Du Jour
BRIEF published on 03/16/2026 at 07:10, 1 month 25 days ago Hypoport Reports Strong Growth in 2025 EBIT Growth Future Outlook Hypoport 2025 Financial Results Mortgage Recovery
BRIEF published on 03/16/2026 at 07:10, 1 month 25 days ago Hypoport prévoit une forte croissance en 2025 Croissance De L'EBIT Perspectives D'avenir Hypoport Résultats Financiers De 2025 Recouvrement Hypothécaire
BRIEF published on 03/16/2026 at 07:07, 1 month 25 days ago Julius Baer Group Announces Board Changes Board Of Directors Julius Baer Group Gender Diversity Olga Zoutendijk Colin Bell
BRIEF published on 03/16/2026 at 07:07, 1 month 25 days ago Le groupe Julius Baer annonce des changements au sein de son conseil d'administration Conseil D'administration Groupe Julius Baer Olga Zoutendijk Colin Bell Diversité Des Genres
BRIEF published on 03/16/2026 at 07:05, 1 month 25 days ago BioVersys Gets FDA Nod for BV100 Phase 3 Trial for Pneumonia FDA Approval Phase 3 Trial BV100 BioVersys CRAB Infections
BRIEF published on 03/16/2026 at 07:05, 1 month 25 days ago BioVersys obtient l'approbation de la FDA pour son essai de phase 3 du BV100 contre la pneumonie Approbation De La FDA Essai De Phase 3 BV100 BioVersys Infections À CRAB
BRIEF published on 03/16/2026 at 07:04, 1 month 25 days ago Julius Baer Releases 2025 Annual and Sustainability Reports Wealth Management Financial Statement Sustainability Report Julius Baer Annual Report 2025
Published on 05/09/2026 at 01:30, 1 day 12 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 13 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 11:45, 2 hours 12 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 18 hours 52 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 17 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 18 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 18 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 18 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 18 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 18 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 18 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 18 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
